↓ Skip to main content

Dove Medical Press

Article Metrics

Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted

Overview of attention for article published in Drug Design, Development and Therapy, March 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
19 Mendeley
Title
Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted
Published in
Drug Design, Development and Therapy, March 2012
DOI 10.2147/dddt.s29916
Pubmed ID
Authors

Olivier Lambert

Abstract

Epoprostenol, used for the treatment of pulmonary arterial hypertension (PAH), has a number of limitations related to its short half-life in aqueous solution. The aim of this study was to evaluate the stability and microbiological properties of a new formulation, namely epoprostenol sodium with arginine and mannitol excipients (epoprostenol AM; Veletri®; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland).

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 32%
Researcher 3 16%
Student > Ph. D. Student 2 11%
Professor 1 5%
Student > Bachelor 1 5%
Other 1 5%
Unknown 5 26%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 32%
Medicine and Dentistry 4 21%
Agricultural and Biological Sciences 1 5%
Economics, Econometrics and Finance 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 1 5%
Unknown 5 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2012.
All research outputs
#7,850,053
of 12,510,237 outputs
Outputs from Drug Design, Development and Therapy
#551
of 1,315 outputs
Outputs of similar age
#66,152
of 119,508 outputs
Outputs of similar age from Drug Design, Development and Therapy
#5
of 11 outputs
Altmetric has tracked 12,510,237 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,315 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,508 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.